11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04982289 (ClinicalTrials.gov)	January 1, 2022	21/6/2021	Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis	A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel Groups, Multicenter Study to Evalu ...	Generalized Myasthenia Gravis	Drug: ALXN1830;Other: Placebo	Alexion Pharmaceuticals	NULL	Withdrawn	18 Years	N/A	All	0	Phase 2	United States

First Previous1Next Last